Argent Trust Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$1.62M Sell
29,839
-345
-1% -$22.5K 0.72% 41
2015
Q2
$2.03M Hold
30,184
0.81% 42
2015
Q1
$1.77M Hold
30,184
0.72% 48
2014
Q4
$1.98M Sell
30,184
-1,012
-3% -$63.8K 0.8% 43
2014
Q3
$1.8M Sell
31,196
-4,286
-12% -$238K 0.7% 48
2014
Q2
$2M Buy
35,482
+227
+0.6% +$11.9K 0.71% 47
2014
Q1
$1.81M Sell
35,255
-280
-0.8% -$14.2K 0.68% 48
2013
Q4
$1.88M Sell
35,535
-256
-0.7% -$12.6K 0.71% 48
2013
Q3
$1.6M Sell
35,791
-450
-1% -$19.9K 0.68% 49
2013
Q2
$1.5M Buy
+36,241
New +$1.59M 0.66% 49

Other funds holding ABBV

Argent Trust Company's ABBV Position: Q3 2015 in Review

Argent Trust Company reduced its AbbVie (ABBV) stake by 1.1% in Q3 2015, selling an estimated $22.5K and leaving 29,839 shares worth $1.62M. The position accounts for 0.72% of the portfolio, ranked #41.

Argent Trust Company first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $2.03M in Q2 2015. 1,605 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • Argent Trust Company held 29,839 shares of AbbVie worth $1.62M as of Q3 2015.
  • Argent Trust Company sold 345 AbbVie shares in Q3 2015, an estimated $22.5K.
  • AbbVie made up 0.72% of Argent Trust Company's portfolio in Q3 2015, its #41 holding.
  • Argent Trust Company first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
  • Argent Trust Company's AbbVie position peaked at $2.03M in Q2 2015.
  • 1,605 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.